News

News and Insights from Our Multidisciplinary Team of Experts

Flagship Spotlight: Michael Argyres, MD

Michael Argyres, MD, is Flagship’s Director of Pathology, diagnostic biomarkers. Mike received his BA at UC Berkeley in molecular biology, his MD at the Medical College of Wisconsin, did his pathology residency at the University of Colorado, a surgical pathology...

read more

Flagship Spotlight: Chuck Caldwell, PhD

Flagship scientist Chuck Caldwell received his PhD in Biological Engineering at the University of Missouri and BS, Biological Engineering, also at the University of Missouri, and did postdoctoral studies at the University of Colorado. He recently shared some of his...

read more

Flagship Biosciences Announces Biocom Membership

Broomfield, CO – April 3, 2019 — Flagship Biosciences, the advanced tissue data services company, today announced its membership in Biocom, the association representing the California life science industry. A Flagship representative will also serve on the Biocom...

read more

Sign up to receive industry and company news, including The Cut Point, Flagship’s quarterly e-newsletter.

Recent Posts

PUBLICATIONS/POSTERS

CIOReview Names Flagship Company of the Year

CIOReview named Flagship Biosciences “Company of the Year,” as part of the publication’s 2018 20 Most Promising Pharma & Life Sciences Tech Solution Providers industry review. “The ease of leveraging Flagship’s powerful solution is yet another massive...

Using Artificial Intelligence to Predict Response to Immunotherapy

Key Concepts: Pathological interpretations applied to PD-L1 IHC as a response biomarker are becoming more complex, going beyond simple tumor proportion score (TPS) and requiring more complex diagnostic algorithms that evaluate the role of PDL1 expression in tumor...

Pathology AI (Artificial Intelligence)

Key takeways:  Successful pathology AI does not replace, but assist pathologists in high-complexity tissue analysis Transparency and control is retained in a pathologist-centric AI-based system Pathology AI enables cost effective healthcare by testing for multiple...

EVENTS

SITC 2022

Visit Flagship at SITC | Booth #818.November 8-12, 2022.Stop by our booth to meet our new CSO Tom Turi, Ph.D., and talk with us about how we can partner with you for end-to-end biomarker support. Come learn about our new services, and pick up a map of our favorite...

World CB & CDx 2022

Visit Flagship at World CB & CDx | Booth #4. Boston, MA | September 26-29, 2022. Stop by our booth to talk with us about how we can partner with you for end-to-end biomarker support and see our latest data. Assay development and validation Clinical trial support...

AACR 2022

Visit Flagship at AACR | Booth #1554. April 8-13, 2022. Stop by our booth to talk with us about how we can partner with you for end-to-end biomarker support, see our latest data from this year’s featured posters, and pick up a map of our favorite NOLA eateries. Assay...